INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q4 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,019,934 | +32.6% | 3,446,334 | +10.8% | 4.70% | +34.0% |
| Q2 2023 | $65,606,947 | +31.2% | 3,109,334 | +6.0% | 3.51% | +66.1% |
| Q1 2023 | $49,992,953 | -0.7% | 2,932,138 | +16.3% | 2.11% | -0.2% |
| Q4 2022 | $50,367,602 | +90.0% | 2,520,901 | +104.8% | 2.12% | +92.2% |
| Q3 2022 | $26,511,000 | -35.3% | 1,230,800 | -40.8% | 1.10% | -29.4% |
| Q2 2022 | $40,992,000 | +32.3% | 2,078,680 | +57.7% | 1.56% | +64.8% |
| Q1 2022 | $30,983,000 | +5.2% | 1,318,432 | +21.9% | 0.95% | +66.0% |
| Q4 2021 | $29,461,000 | +7.1% | 1,081,532 | +8.3% | 0.57% | +23.1% |
| Q3 2021 | $27,505,000 | +119.1% | 998,732 | +126.4% | 0.46% | +146.3% |
| Q2 2021 | $12,553,000 | +11.8% | 441,065 | +30.8% | 0.19% | +17.5% |
| Q4 2020 | $11,224,000 | +3.6% | 337,145 | 0.0% | 0.16% | -17.9% |
| Q3 2020 | $10,836,000 | -56.1% | 337,145 | -62.4% | 0.20% | -63.2% |
| Q2 2020 | $24,664,000 | +2209.4% | 895,560 | +1244.7% | 0.53% | +1727.6% |
| Q1 2020 | $1,068,000 | – | 66,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,056,797 | $33,965,000 | 14.39% |
| Palo Alto Investors LP | 6,032,956 | $193,899,000 | 10.64% |
| Sycale Advisors (NY) LLC | 360,829 | $11,597,000 | 9.99% |
| Burrage Capital Management LLC | 165,400 | $5,316,000 | 4.20% |
| First Light Asset Management, LLC | 1,025,341 | $32,954,000 | 3.38% |
| Rubric Capital Management LP | 1,100,000 | $35,354,000 | 3.30% |
| Sofinnova Investments, Inc. | 615,143 | $19,771,000 | 1.47% |
| Endurant Capital Management LP | 144,313 | $4,638,000 | 1.37% |
| Parkwood LLC | 70,235 | $5,514,000 | 0.85% |
| Novo Holdings A/S | 430,107 | $13,824,000 | 0.69% |